EDIT
Editas Medicine Inc
Clinical-stage biotechnology company focused on CRISPR gene editing therapies
CUSIP: 28106W103HealthcareUS1 holder
Total Value
$33.37M
Total Shares
931.4K
Net Share Change
-103.9K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$33.37M931.4K shares
TRIM-103.9K(-10.0%)